Correlation Between Aridis Pharmaceuticals and Transgene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aridis Pharmaceuticals and Transgene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aridis Pharmaceuticals and Transgene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aridis Pharmaceuticals and Transgene SA, you can compare the effects of market volatilities on Aridis Pharmaceuticals and Transgene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aridis Pharmaceuticals with a short position of Transgene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aridis Pharmaceuticals and Transgene.

Diversification Opportunities for Aridis Pharmaceuticals and Transgene

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Aridis and Transgene is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Aridis Pharmaceuticals and Transgene SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transgene SA and Aridis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aridis Pharmaceuticals are associated (or correlated) with Transgene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transgene SA has no effect on the direction of Aridis Pharmaceuticals i.e., Aridis Pharmaceuticals and Transgene go up and down completely randomly.

Pair Corralation between Aridis Pharmaceuticals and Transgene

If you would invest  159.00  in Transgene SA on August 24, 2024 and sell it today you would earn a total of  0.00  from holding Transgene SA or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy4.55%
ValuesDaily Returns

Aridis Pharmaceuticals  vs.  Transgene SA

 Performance 
       Timeline  
Aridis Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aridis Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Aridis Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Transgene SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Transgene SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Transgene is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.

Aridis Pharmaceuticals and Transgene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aridis Pharmaceuticals and Transgene

The main advantage of trading using opposite Aridis Pharmaceuticals and Transgene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aridis Pharmaceuticals position performs unexpectedly, Transgene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transgene will offset losses from the drop in Transgene's long position.
The idea behind Aridis Pharmaceuticals and Transgene SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets